Always consult with your doctor for recommendations specific to your body and health conditions
The type of GLP-1RA therapy appeared to influence the risk of composite outcomes (Additional file 1: Table S9)
Storage duration and conditions are determined by product-specific stability testing, and the only authoritative source of storage instructions for retatrutide is your clinical trial protocol, study sponsor, or dispensing pharmacy
Koeth Robert A., Wang Zeneng, Levison Bruce S., Buffa Jennifer A., Org Elin, Sheehy Brendan T., Britt Earl B., Fu Xiaoming, Wu Yuping, Li Lin, Smith Jonathan D., DiDonato Joseph A., Chen Jun, Li Hongzhe, Wu Gary D., Lewis James D., Warrier Manya,Brown J
Harper, L